You searched for "retinal"

3491 results found

Effect of change in retinal nerve fibre layer thickness on quality of life in patients with glaucoma

The authors investigated the relationship between structural changes in glaucoma (retinal nerve fibre layer (RNFL) thickness) and quality of life (as measured by the NEI VFQ-25 questionnaire) over a period of time. Two hundred and sixty eyes of 130 patients...

Treatment of Type 1 ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone

This is a retrospective review of charts of 54 consecutive very low birth weight (VLBW) infants between June 2011 and January 2015 from Berlin, Germany. Type 1 ROP (posterior ROP, n=33; peripheral zone 2, n= 21) were treated with either...

IVTA for diabetic macular edema and macular edema secondary to retinal vein occlusion: a meta-analysis

This meta-analysis aimed to compare the safety and efficacy of different doses of intravitreal triamcinolone acetonide (IVTA) for diabetic macular oedema (DME) and macular oedema (ME) secondary to retinal vein occlusion (RVO). A systematic literature search for randomised controlled trials...

Comparison of retinal pigment epithelium-choroid graft surgery and anti-VEGF therapy in patients with wet AMD

This was a randomised intervention study in wet AMD patients to investigate benefits of free RPE-choroid graft transplantation surgery versus (continuation of) anti-VEGF treatment. Twenty patients who met the inclusion criteria were subdivided into three subgroups, i.e. RPE tears involving...

Can coenzyme Q10 have a protective role in ethambutol-induced retinal ganglion cell toxicity

Tuberculosis (TB) is one of the most prevalent infectious diseases, especially in developing or low- income countries. Ethambutol is a widely used drug to treat TB. Ethambutol can cause visual disturbance including ethambutol toxic optic neuropathy (ETON). ETON is one...

Chandelier-assisted versus standard scleral buckling for rhegmatogenous retinal detachment repair. Systematic review and meta-analysis

Despite a significant global decline in standard scleral buckling (SSB) procedures for rhegmatogenous retinal detachment (RRD), it continues to hold its place as an essential treatment option, offering distinct advantages such as cost-effectiveness, preservation of the vitreous, improved final visual...

Through the eyes of artists, part two: The effects of retinal degeneration on Degas and O’Keeffe

Last issue we discussed Monet and Cassatt’s experience of painting through cataract. We now move to two stories of resilience in the face of macular degeneration, Edgar Degas and Georgia O’Keeffe. Edgar Degas. (c1873) ‘The Dance Class’, oil on canvas....

Outcomes at 100 weeks from the LEAVO study of intravitreal anti-VEGF therapies for macular oedema secondary to central retinal vein occlusion

Royal College of Ophthalmologists Annual Congress 2019, Glasgow - First presented and discussed on Monday 20 May 2019, with a further presentation of results during Retina Subspecialty Day on Thursday 23 May 2019. Among patients with macular oedema secondary to...

Outcomes following repair of early-onset versus delayed-onset rhegmatogenous retinal detachments (RD) after acute posterior vitreous detachment (PVD)

This is a retrospective single centre comparative interventional study of 210 patients in total, between 2015 to 2020, presenting with delayed RD (diagnosed >42 days after initial acute PVD presentation) compared with a 2:1 age and gender-matched acute RD cohort...

Persistent subretinal fluid (PSFF) in pneumatic retinopexy (PNR) versus pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD): posthoc analysis of the PIVOT randomised trial

This is a posthoc study of the PIVOT randomised trial over a 12 month period, to evaluate the functional outcomes of the incidence of PSF in PnR versus PPV following RRD surgery. One hundred and fifty-eight patients were recruited and...

Moorfields to start new retinal detachment clinical trial

Moorfields to start new retinal detachment clinical trial following £1.2 million MRC DPFS grant awarded to UCL and Moorfields Eye Hospital.